FDA Device Intelligence
Home › RANDOX LABORATORIES LIMITED › SEROLOGY I POSITIVE CONTROL (SEROLOGY I CONTROL +)

SEROLOGY I POSITIVE CONTROL (SEROLOGY I CONTROL +)

RANDOX LABORATORIES LIMITED · Model SR10352 · UDI-DI 05055273216509

OHQ Prescription
0
510(k) clearances
6
Adverse events
27
Recalls
57
Facilities

Description

Serology I Postive Control is intended for use with in vitro assays for determination of antibodies to Human Immunodeficiency Virus Type 1 and 2 (HIV-1/2), antibodies to Human T-Lymphotropic Virus Type 1 and 2 (HTLV-1/2), antibodies to Hepatitis C Virus (HCV), Hepatitis B Surface Antigen (HBsAg), IgG antibodies to Hepatitis B Core Antibodies (HBc) and IgG antibodies to Treponema pallidum. Serology I Positive Control is unassayed without target values and is suitable for use on many analysers. These controls must not be used as a substitute for the mandatory manufacturer’s kit controls provided with the assay. Serology I Positive Control is helpful in determining the precision of testing systems and in identifying sources of variation.

Recalls

DateFirmReason
2026-08-14TECHNO-PATH MANUFACTURING LTD.A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing con
2026-08-14TECHNO-PATH MANUFACTURING LTD.A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing con
2026-08-14TECHNO-PATH MANUFACTURING LTD.A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing con
2025-10-17TECHNO-PATH MANUFACTURING LTD.Potential of negative recovery of the HBsAg analyte across two (2) lots of Multichem ID-B Positive Control when tested on the Alinity i platform.
2025-10-17TECHNO-PATH MANUFACTURING LTD.Potential of negative recovery of the HBsAg analyte across two (2) lots of Multichem ID-B Positive Control when tested on the Alinity i platform.
2025-02-20Microbiologics IncThe RSV target may give a late Ct value and could potentially not pass QC.
2025-02-20Microbiologics IncThe A549 human cell target (human cells for sample adequacy control) may give a late Ct value.
2025-01-20Microbiologics IncInternal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed
2025-01-20Microbiologics IncInternal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed
2024-01-08Microbiologics IncThe negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the neg

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.